Results 161 to 170 of about 360,869 (356)
International Journal of Cancer, EarlyView.What's New? The combination of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma has demonstrated durable response and tolerability in clinical trials. However, inclusion criteria for clinical studies are restrictive, and patients in the real‐world setting tend to have more comorbidities.
Hendrik Dinkel +21 more
wiley +1 more source
Building a More Inclusive Urology Workforce: Lessons from Successful Initiatives. [PDF]
J Healthc LeadershChan SJ, Harris CL, Badalato GM.
europepmc +1 more source
Competitiveness for urology training and gender diversity in higher surgical training in Ireland
, 2021 Kjrsten Keane, Rustom P. Manecksha
openalex +1 more source
Living at genetic risk: The patient experience of Lynch syndrome
International Journal of Cancer, EarlyView.Abstract Lynch syndrome is a germline cancer predisposition syndrome caused by a variant in one of four genes. Lynch syndrome places individuals at significantly higher risk for a range of cancers, especially colorectal and endometrial. Depending on which gene is affected, the risk of ovarian, gastric, small bowel, pancreatic, biliary urothelial, brain,
Nicola Reents +2 more
wiley +1 more source
Influence of sheath size on suction mini-PCNL outcomes: An observational study from the EAU endourology section and the global suction in mini-PCNL collaborative study group. [PDF]
BJUI CompassGauhar V +17 more
europepmc +1 more source